Safety of Venous Thromboembolism Pharmacological Prophylaxis in Hospitalized Patients With Inflammatory Bowel Disease (VISCOUS Study)

Key Points

• To assess the safety of pharmacological VTE prophylaxis in hospitalized patients with inflammatory bowel disease (IBD).
• Conducted a study evaluating patients admitted with IBD exacerbation.
• Analyzed bleeding events during the use of VTE prophylaxis.
• Considered high-risk populations for future research.
• No increased risk of bleeding observed in patients receiving VTE prophylaxis durante hospitalization.
• The need for additional data on high-risk patients was identified.